What does Oaktree Acquisition Corp. III Life Sciences do?

Oaktree Acquisition Corp. III Life Sciences is a public company in the Blank Checks industry, incorporated in E9. It is registered with the SEC under CIK 0002029769 and trades on NASDAQ under the ticker OACCW.

Is Oaktree Acquisition Corp. III Life Sciences profitable?

Oaktree Acquisition Corp. III Life Sciences was profitable in FY2025, reporting net income of $7.29M. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Oaktree Acquisition Corp. III Life Sciences made?

Oaktree Acquisition Corp. III Life Sciences has filed 52 documents with the SEC since 2024. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Oaktree Acquisition Corp. III Life Sciences

OACCW NASDAQ CIK: 0002029769 Blank Checks Inc. in E9

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 52 filings →

Form	Description	Date
10-K	10-K	Mar 26, 2026
10-Q	10-Q	Nov 13, 2025
3	3	Oct 29, 2025
8-K	8-K	Oct 29, 2025
3	3	Oct 22, 2025
8-K	8-K	Oct 17, 2025
10-Q	10-Q	Aug 12, 2025
SCHEDULE 13G/A	—	Jul 15, 2025
3	3	Jun 16, 2025
8-K	8-K	Jun 6, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Oaktree Acquisition Corp. III Life Sciences. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: $7.29M (FY2025)
Total Assets: $203.11M (FY2025)
Operating Income: ($1.20M)

Full financials →

Details

CIK: 0002029769
Ticker: OACCW
Exchange: NASDAQ
Incorporated: E9
First Filing: 2024
Total Filings: 52

Blank Checks rankings →